Could a triple-drug cocktail finally relieve long COVID?
NCT ID NCT07597902
First seen May 25, 2026 · Last updated May 25, 2026
Summary
This study tests whether a combination of three drugs—valacyclovir, celecoxib, and Paxlovid—can reduce Long COVID symptoms in 150 adults aged 18-65. Participants will receive either the drug combo or a placebo. The goal is to improve overall health and quality of life, as measured by a self-rated health scale.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LONG COVID are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The Cohen Center for Recovery from Complex Chronic Illnesses (CoRE)
New York, New York, 10029, United States
Contact Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.